New scalp injection could regrow hair in balding men

NCT ID NCT07327359

Recruiting now Disease control Sponsor: Olix Pharmaceuticals, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests an experimental drug called OLX72021 in 158 men with mild to moderate male pattern baldness. The drug is injected into the scalp at different doses to see if it is safe and can increase hair count compared to a placebo. The trial is currently recruiting participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: OLX72021 (an experimental drug injected into the scalp)
What this could lead to: If it works, this could lead to a new treatment option for male pattern baldness that helps regrow hair.
What could go wrong: This is an early-phase trial (Phase 1b/2a) with a small number of participants. The drug may not work better than placebo, and side effects from the injections are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA (AGA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alopecia androgenetic alopecia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANDROGENETIC ALOPECIA (AGA)

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Emeritus Research Camberwell
RECRUITING

Camberwell, Victoria, 3124, Australia

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.